2021

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.


 
Letter to HHS Secretary on Medicare & Medication Access
02/25/2021
Letter to HHS Secretary-designee Becerra, expressing opposition to a proposal that would undermine key patient protections in Medicare's prescription drug program.
Letter to Congressional Committee Leadership on Nomination
02/25/2021
Letter to Senate HELP Committee Leadership, expressing support for the nomination of Vivek Murthy, M.D., M.B.A. as the 21st Surgeon General of the United States.
Letter to Congressional Leadership on Medicaid & Crisis Services
02/25/2021
Letter to Congressional Leadership, expressing support for enhanced federal Medicaid support for community-based mobile crisis intervention services as currently included in the proposed American Rescue Plan Act for individuals experiencing mental health and substance-use disorder crises.
Letter to Congressional Bill Sponsors on Medicaid & Criminal Justice
02/24/2021
Letter to Congressional Bill Sponsors, expressing support of the Medicaid Reentry Act, which would permit Medicaid to provide essential health care for people in incarcerated settings 30 days prior to their release.
Letter to Congressional Committee Leadership on HHS Nomination
02/23/2021
Letter to Senate Finance Leadership, expressing support for the nomination of Xavier Becerra as the next Secretary of the U.S. Department of Health and Human Services (HHS).
Letter to HHS Secretary on COVID-19
02/23/2021
Letter to HHS Acting Secretary Cochran, expressing thanks for the recent letter to Governors stating the public health emergency (PHE) declaration will likely remain in place throughout 2021.
Letter to Congressional Leadership on COVID-19 & Medicaid
02/23/2021
Letter to Congressional leadership, expressing support for the provision in the COVID relief reconciliation bill that will provide would provide additional funding for the direct care workforce within Medicaid Home and Community Based Services (HCBS).
Letter to Congressional Committee Leadership on COVID-19 & Telehealth
02/22/2021
Letter to Senate HELP & House Energy & Commerce Leadership, expressing support of the recent reintroduction of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708/S. 168), which would expand access to telehealth during the COVID public health emergency.
Letter to FDA Director on Medication Access
02/22/2021
Letter to FDA Center for Drug Evaluation and Research Director Choe, urging the FDA to commit to increased efficiency of generic reviews and greater attention to complex generics.
Comments to HHS Secretary on Medicaid
02/19/2021
Regulatory comments to HHS Acting Secretary Cochran, expressing support for Washington State’s request to extend a Medicaid demonstration program with an Institute for Mental Disease (IMD) waiver component.
Displaying results 31-40 (of 65)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7  >